Mortality Among Individuals Diagnosed With Chronic Beryllium Disease and Beryllium Sensitization.

Individuals with CBD had an overall increased mortality risk due to increased respiratory mortality regardless of their duration of exposure to beryllium. Individuals with BeS did not have increased respiratory mortality. No increased risk of lung cancer was seen among this cohort.